Giorn. It. Ost. Gin. Vol. XXVII - n. 7-8
Vaginal infections: epidemiology and risk factors
Summary: Vaginal infections: epidemiology and risk factors.
Vaginitis is the most common gynaecologic condition encountered by physicians in the office. The actual frequency of vaginitis is difficult to ascertain, due to numerous confounding factors, such as a high asymptomatic rate, inaccurate self-diagnosis and treatment. Vaginitis affects all races and age groups.
Bacterial vaginosis (BV), vaginal candidiasis, and T. vaginalis infection are thought to cause approximately 90% of all vaginal infections.
Recently, the term “aerobic vaginitis” has been proposed to define a “new” vaginal pathology characterised by pH values above 5, yellowish and foul smelling secretions (though negative at the KOH test), inflammatory and dyspareunia manifestations, the lack of increase in anaerobic microrganisms and the presence of aerobic bacteria from the rectal reservoir.
A complex and intricate balance of microorganisms maintains the normal vaginal flora. Important organisms include lactobacilli, corynebacteria, and yeast. Hormones further influence this microenvironment: the decrease in estrogens can result in an altered risk of infection. The normal postmenarchal and premenopausal vaginal pH is 3.8-4.2. At this pH, growth of pathogenic organisms usually is inhibited.
Disturbance of the normal vaginal pH can alter the vaginal flora, leading to overgrowth of pathogens.
Factors that alter vaginal environment include feminine hygiene products, contraceptives, vaginal medications, antibiotics, sexually transmitted diseases (STDs), sexual intercourse, and stress.
Riassunto: Infezioni vaginali: epidemiologia e fattori di rischio.
La vaginite è la più comune condizione ginecologica di riscontro ambulatoriale. La frequenza attuale della vaginite è di difficile determinazione, a causa dei numerosi fattori confondenti, quali l’elevata assenza di sintomi, auto-diagnosi e trattamento inaccurati.
La vaginite colpisce tutte le razze e le fasce di età.
Vaginosi Batterica (BV), candidiasi vaginale, e T. vaginalis sono ritenute la cause di circa il 90% di tutte le infezioni vaginali.
Recentemente, il termine “vaginite aerobica” è stato proposto per definire una “nuova” patologia vaginale caratterizzata da valori di pH > 5, secrezioni maleodoranti e giallastre (sebbene negative al test KOH), manifestazioni infiammatorie e dispareunia, la mancanza di aumento di microrganismi anaerobi e la presenza di batteri aerobi dall’ambiente rettale.
Un complesso equilibrio di microrganismi mantiene la flora vaginale nella normalità. Importanti organismi includono lattobacilli, corynebacteri e lieviti. Inoltre, gli ormoni influenzano questo microambiente: la diminuzione degli estrogeni può portare ad un alterato rischio di infezioni. Il pH vaginale normale postmenarca e premenopausa è di 3.8-4.2. A questo pH, la crescita di organismi patogeni è solitamente inibita.
Alterazioni del normale pH vaginale (prodotti per l’igiene intima, contraccettivi, topici vaginali, antibiotici, malattie sessualmente trasmesse (STDs), rapporti sessuali e stress, possono modificare la flora vaginale, portando a sovracrescita di patogeni.
Vaginitis is a very common disease, affecting millions of women and is one of the primary reasons why women visit their doctor, but, among these, the true incidence of vaginal infections is difficult to ascertain, since most women and sometimes their doctors use the term vaginitis as a synonym for infections, assuming that all vulvovaginal irritations or itching, especially when accompanied by abnormal secretions, is caused by microorganisms.
When symptoms are acute, infection is the most common cause, but chronic symptoms often have different or additional aetiologies, and any patient with vaginitis who does not respond to antinfective therapy should have her infection confirmed by laboratory tests.
Furthermore, the actual frequency of infectious vaginitis is also difficult to ascertain, due to numerous confounding factors, such as a high asymptomatic rate, inaccurate self-diagnosis and treatment, and population dependence. In the USA, the reported rate at general gynaecologic clinics is 5-15%, while for STD clinics, reported rates range from 32% to as high as 64%.
European rates are uncertain but probably are
similar to those in the
Vaginitis affects all races, but the highest incidence is in African Americans and the lowest incidence is in Asians. All age groups are affected, even if the highest incidence is noted among young, sexually active women.
Among infectious vaginitis we can consider some very rare syndromes such as atrophic vaginitis with secondary bacterial infection, foreign body with secondary bacterial infection, ulcerative vaginitis associated with S. aureus and toxic shock syndrome and idiopathic vulvovaginal ulceration associated with HIV, but the most common causes of the vast majority of the lower genital tract infections, are yeasts (such as Candida species), protozoa (Trichomonas vaginalis) and selected anaerobic vaginal bacteria (such as Gardnerella vaginalis, peptococcus…).
These microrganisms are responsible for the three most common diseases associated with vaginal infection, that is trichomoniasis (from 5 to 20%), bacterial vaginosis (40-50%), and vulvovaginal candidiasis (20-35%), not infrequently, in combination.
The rate of incidence can be different according to area or time of recording, but constantly T. vaginalis shows the lowest incidence, even if their absolute value is high and it may be emerging as one of the most important cofactors in amplifying HIV transmission (Fig.1).
The second most common cause of vaginal infection is candidiasis.
In the second half of the last century, the incidence of vaginal candidiasis increased dramatically (1).
It is estimated that 75% of women experience at least one episode of vulvovaginal candidiasis during their childbearing age, and approximately 40% experience a second attack.
A small, not determinable, subpopulation of women (less than 10%) suffers from recurrent, often intractable episodes.
Apart from genetic factors such as blood group antigen/secretor status, acquired host factors associated with asymptomatic vaginal colonization by candida and with candida vaginitis (Fig.2) could be responsible for the increase.
• pregnancy (may reduce the immune system’s ability to fight infections);
• diabetes (body secretions, including vaginal secretions, have increased glucose levels and body tissues stop functioning normally and this impairs the immune system’s ability to fight infection;
• the number of sexual partners generally has no correlation with yeast infections even if;
• oral sex: transmission possible if person has yeast in mouth;
• oral contraceptives (more women have sexual intercourse and the ejaculate is a very strong immuno-suppressive agent and can harm local immune response);
• other contraceptives (I.U.D., diaphragm, cervical cap can change the vaginal flora).
It is also significant that the percentage of non-albicans Candida infections is also rising dramatically.
In the 1970s, the incidence of non-albicans vaginal infections was approximately 5% to 10%, and in the 1980s it increased from 15% to 25%.
A study in the 1980s involving 728 isolates from women with vaginal candidiasis showed in England a prevalence of 21.3% non-albicans species (1), while in Italy, Parazzini F. et al. (4) in 2000, registered an extremely high isolation rate of non-albicans species (50.9%).
A more recent epidemiological study did not confirm these Italian data.
In fact, Corsello S.
et al. (2) showed, in a multicentre study involving 8
Italian Gynecological and
Among non-albicans species, C. glabrata was the most isolated.
From a worldwide perspective, bacterial vaginosis (BV) continues to be the leading variety of vaginal infections.
Bacterial vaginosis has been defined as a polymicrobial alteration in vaginal flora causing an increase in vaginal pH, sometimes associated with a homogenous discharge, but in the absence of a demonstrable inflammatory response (Eschenbach et al., 1988).
It can be easily diagnosed by “Amsel’s criteria”:
1. a thin, milky white discharge that clings to the walls of the vagina,
2. presence of a fishy odor (a positive amine test ),
3. a vaginal pH greater than 4.5,
4. the presence of “clue cells” (vaginal cells that are covered with small bacteria) in the vaginal smears.
BV is not caused by a particular organism but there is a change in the balance of normal vaginal bacteria with a very high number of bacteria such as Gardnerella vaginalis, Mycoplasma hominis, Bacteroides species, and Mobiluncus species.
These bacteria can be found in numbers from 100 to 1,000 times greater than found in the healthy vagina. In contrast, Lactobacillus bacteria are in very low numbers or completely absent.
Recently, Donders (3) proposed the term “aerobic vaginitis” to define a “new” vaginal pathology (neither classifiable as specific vaginitis nor as BV) characterised by pH values above 5, yellowish and foul smelling secretions (though negative at the KOH test), and inflammatory and dyspareunia manifestations (Fig.5).
From the microbiological point of view, (5) this is different from BV because of the lack of increase in anaerobic microrganisms and the presence of aerobic bacteria from the rectal reservoir (especially E.coli).
It is therefore indicative of an alteration of the vaginal homeostasis with a consequent increase of enteric bacteria vaginal colonization.
Therefore I propose a new classification of vaginal infections, including aerobic vaginitis together with vaginosis in a group of vaginal ecological disorders (Fig.7).
Importance of vaginal ecosystem
It is well known that vaginitis results from alterations in the vaginal ecosystem, either by the introduction of an organism or by a disturbance that allows normally present pathogens to proliferate. The vaginal flora is highly susceptible to numerous endogenous and exogenous influences, such as contraceptives, vaginal medications, antibiotics, sexually transmitted diseases (STDs), sexual intercourse, and stress.
As regards feminine hygiene products, it is extremely important to choose the best douching; that means not only not containing harsh solution but also respecting the different pHs that characterize the vaginal ecosystem during a women’s life.
1. Bingham J.S.: Vulvovaginal candidiasis: an overview. Acta Derm Venereol 1986; 121: 39, 46.
2. Corsello S. et al.: An epidemiological survey of vulvovaginal candidiasis. In
3. Donders G. et al.: Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis; BJOG, January 2002.
4. Parazzini F. et al.: Determinants of different Candida species infections of the genital tract in Sporachrom study group. Eur.J.Obstet Gynecol Reprod Biol; 2000; 93(2): 141-5.
5. Tempera G. et al.: Microbiological/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis: a pilot study. Int. J. Antimicrob. Agents, 2004; 24(1): 85-8.